Yuling Li

发表

Structural basis of BLyS receptor recognition

Eddy Arnold, E. Arnold, R. Gentz, 2002, Nature Structural Biology.

Swapan Amino-Terminal Alanine-Methionine Protein 4, a Property Strongly Enhanced by -Chemokine Macrophage Inflammatory b the C-C Chemokine Receptor 3 Antagonism by

B. Nardelli, H. Olsen, Yuling Li, 2022 .

Prote in 4 ( MCP-4 ) , a Nove l Structural and Funct iona l

B. Dewald, M. Baggiolini, P. Loetscher, 2003 .

CC Chemokine Receptor 1 Dendritic Cells by MPIF-1 , a Specific Ligand Pathway Activated in Human Monocytes and Characterization of the Signal Transduction and

B. Nardelli, Yuling Li, P. Murphy, 1998 .

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

B. Kwon, B. Aggarwal, J. Greene, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1

B. Nardelli, H. Olsen, Yuling Li, 2000, The Journal of Immunology.

Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2 Cystatins*

R. Gentz, D. Parmelee, T. Coleman, 1997, The Journal of Biological Chemistry.

Molecular and Functional Characterization of Two Novel Human C-C Chemokines as Inhibitors of Two Distinct Classes of Myeloid Progenitors

R. Gentz, D. Parmelee, B. Nardelli, 1997, The Journal of experimental medicine.

B Lymphocyte Stimulator (BLyS): A Therapeutic Trichotomy for the Treatment of B Lymphocyte Diseases

P. Moore, B. Nardelli, D. Hilbert, 2002, Leukemia & lymphoma.

Modulation of T-cell responses to alloantigens by TR 6 / DcR 3

Yun Hee Cho, P. Moore, P. Feng, 2018 .

Solution Structure and Dynamics of Myeloid Progenitor Inhibitory Factor-1 (MPIF-1), A Novel Monomeric CC Chemokine*

R. Gentz, K. Rajarathnam, Yuling Li, 2001, The Journal of Biological Chemistry.

Optimization of BLyS production and purification from Escherichia coli.

Robert N. Burke, O. Galperina, Michael W. Laird, 2005, Protein expression and purification.

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

Amy S Orr, P. Moore, O. Belvedere, 1999, Science.

Modulation of T-cell responses to alloantigens by TR6/DcR3.

H Chen, Yun Hee Cho, P. Moore, 2001, The Journal of clinical investigation.

Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice.

Y. Li, J. Carrell, S. Sosnovtseva, 2001, The Journal of pharmacology and experimental therapeutics.